C. H. Clegg, T. A. Linkhart, B. B. Olwin, and S. D. Hauschka, Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor, The Journal of Cell Biology, vol.105, issue.2, pp.949-956, 1987.
DOI : 10.1083/jcb.105.2.949

N. E. Olson, E. Sternberg, J. S. Hu, G. Spizz, and C. Wilcox, Regulation of myogenic differentiation by type beta transforming growth factor, The Journal of Cell Biology, vol.103, issue.5, pp.1799-1805, 1986.
DOI : 10.1083/jcb.103.5.1799

A. Musarò and N. Rosenthal, Maturation of the Myogenic Program Is Induced by Postmitotic Expression of Insulin-Like Growth Factor I, Molecular and Cellular Biology, vol.19, issue.4, pp.3115-3124, 1999.
DOI : 10.1128/MCB.19.4.3115

A. Musarò, K. J. Mccullagh, F. J. Naya, E. N. Olson, and N. Rosenthal, IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1, Nature, vol.400, issue.6744, pp.581-585, 1999.

G. Strassmann, M. Fong, J. S. Kenney, and C. O. Jacob, Evidence for the involvement of interleukin 6 in experimental cancer cachexia., Journal of Clinical Investigation, vol.89, issue.5, pp.1681-1684, 1992.
DOI : 10.1172/JCI115767

S. C. Miller, H. Ito, H. M. Blau, and F. M. Torti, Tumor necrosis factor inhibits human myogenesis in vitro., Molecular and Cellular Biology, vol.8, issue.6, pp.2295-2301, 1988.
DOI : 10.1128/MCB.8.6.2295

D. Coletti, E. Yang, G. Marazzi, and D. Sassoon, TNFalpha inhibits skeletal myogenesis through a PW1-dependent pathway by recruitment of caspase pathways, The EMBO Journal, vol.21, issue.4, pp.631-642, 2002.
DOI : 10.1093/emboj/21.4.631

D. C. Guttridge, M. W. Mayo, L. V. Madrid, C. Wang, J. Baldwin et al., NF-kappa B-Induced Loss of MyoD Messenger RNA: Possible Role in Muscle Decay and Cachexia, Science, vol.289, issue.5488, pp.2363-2365, 2000.
DOI : 10.1126/science.289.5488.2363

P. Muñoz-cánoves, C. Scheele, B. K. Pedersen, and A. L. Serrano, Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?, FEBS Journal, vol.302, issue.Suppl 2, pp.4131-4148, 2013.
DOI : 10.1111/febs.12338

B. K. Pedersen and M. A. Febbraio, Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6, Physiological Reviews, vol.88, issue.4, pp.1379-1406, 2008.
DOI : 10.1152/physrev.90100.2007

B. Baeza-raja and P. Muñoz-cánoves, p38 MAPK-induced Nuclear Factor-??B Activity Is Required for Skeletal Muscle Differentiation: Role of Interleukin-6, Molecular Biology of the Cell, vol.15, issue.4, pp.2013-2026, 2004.
DOI : 10.1091/mbc.E03-08-0585

M. Hoene, H. Runge, H. U. Häring, E. D. Schleicher, and C. Weigert, Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway, AJP: Cell Physiology, vol.304, issue.2, pp.128-136, 2013.
DOI : 10.1152/ajpcell.00025.2012

A. L. Serrano, B. Baeza-raja, E. Perdiguero, M. Jardí, and P. Muñoz-cánoves, Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle Hypertrophy, Cell Metabolism, vol.7, issue.1, pp.33-44, 2008.
DOI : 10.1016/j.cmet.2007.11.011

F. D. Benedetti, C. Meazza, and A. Martini, Role of Interleukin-6 in Growth Failure: An Animal Model, Hormone Research in Paediatrics, vol.58, issue.1, pp.24-27, 2002.
DOI : 10.1159/000064757

S. Franckhauser, I. Elias, and V. R. Sopasakis, Overexpression of Il6 leads to hyperinsulinaemia, liver inflammation and reduced body weight in mice, Diabetologia, vol.101, issue.Suppl 2, pp.1306-1316, 2008.
DOI : 10.1007/s00125-008-0998-8

F. Haddad, F. Zaldivar, D. M. Cooper, and G. R. Adams, IL-6-induced skeletal muscle atrophy, Journal of Applied Physiology, vol.98, issue.3, pp.911-917, 2005.
DOI : 10.1152/japplphysiol.01026.2004

R. L. Perry and M. A. Rudnick, Molecular mechanisms regulating myogenic determination and differentiation, Frontiers of Bioscience, vol.1, issue.5, pp.750-767, 2000.

Y. Tanaka, H. Eda, and T. Tanaka, Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice, Cancer Research, vol.50, issue.8, pp.2290-2295, 1990.

P. Bonaldo and M. Sandri, Cellular and molecular mechanisms of muscle atrophy, Disease Models & Mechanisms, vol.6, issue.1, pp.25-39
DOI : 10.1242/dmm.010389

B. M. Scicchitano, E. Rizzuto, and A. Musarò, Counteracting muscle wasting in aging and neuromuscular diseases: the critical role of IGF-1, Aging, vol.1, issue.5, pp.451-457, 2009.
DOI : 10.18632/aging.100050

X. Wang, W. Li, M. Williams, N. Terada, D. R. Alessi et al., Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase, The EMBO Journal, vol.20, issue.16, pp.4370-4379, 2001.
DOI : 10.1093/emboj/20.16.4370

M. Pelosi, F. Marampon, and B. M. Zani, ROCK2 and Its Alternatively Spliced Isoform ROCK2m Positively Control the Maturation of the Myogenic Program, Molecular and Cellular Biology, vol.27, issue.17, pp.6163-6176, 2007.
DOI : 10.1128/MCB.01735-06

P. P. Roux, B. A. Ballif, R. Anjum, S. P. Gygi, and J. Blenis, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase, Proceedings of the National Academy of Sciences, vol.101, issue.37, pp.13489-13494, 2004.
DOI : 10.1073/pnas.0405659101

S. Lokireddy, I. W. Wijesoma, and S. Bonala, Myostatin is a novel tumoral factor that induces cancer cachexia, Biochemical Journal, vol.117, issue.1, pp.23-36, 2012.
DOI : 10.1038/nrm3028

. Rudnicki, Cellular dynamics in the muscle satellite cell niche, EMBO Reports, vol.14, issue.12, pp.1062-1072, 2013.

M. Mihara, M. Hashizume, H. Yoshida, M. Suzuki, and M. Shiina, IL-6/IL-6 receptor system and its role in physiological and pathological conditions, Clinical Science, vol.69, issue.4, pp.143-159, 2012.
DOI : 10.1038/clpt.2009.313

P. C. Heinrich, I. Behrmann, S. Haan, H. M. Hermanns, G. Müller-newen et al., Principles of interleukin (IL)-6-type cytokine signalling and its regulation, Biochemical Journal, vol.374, issue.1, pp.1-20, 2003.
DOI : 10.1042/bj20030407

X. Peng, P. Xu, and M. Chen, Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2, Genes & Development, vol.17, issue.>11, pp.1352-1365, 2003.
DOI : 10.1101/gad.1089403

M. Sandri, Signaling in Muscle Atrophy and Hypertrophy, Physiology, vol.23, issue.3, pp.160-170, 2008.
DOI : 10.1152/physiol.00041.2007

M. H. Zaki, J. A. Nemeth, and M. Trikha, CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice, International Journal of Cancer, vol.48, issue.4, pp.592-595, 2004.
DOI : 10.1002/ijc.20270

S. L. Deshmane, S. Kremlev, S. Amini, and B. E. Sawaya, Monocyte Chemoattractant Protein-1 (MCP-1): An Overview, Journal of Interferon & Cytokine Research, vol.29, issue.6, pp.313-325, 2009.
DOI : 10.1089/jir.2008.0027

H. Sell, D. Dietze-schroeder, U. Kaiser, and J. Eckel, Monocyte Chemotactic Protein-1 Is a Potential Player in the Negative Cross-Talk between Adipose Tissue and Skeletal Muscle, Endocrinology, vol.147, issue.5, pp.2458-2467, 2006.
DOI : 10.1210/en.2005-0969

J. A. Carson and K. A. Baltgalvis, Interleukin 6 as a Key Regulator of Muscle Mass during Cachexia, Exercise and Sport Sciences Reviews, vol.38, issue.4, pp.168-176, 2010.
DOI : 10.1097/JES.0b013e3181f44f11